Bystronic reports improved H1 results despite challenging market conditions

Bystronic reported H1 2025 order intake of CHF 309 million and revenue of CHF 305 million, largely aligning with analyst expectations. A key highlight was the significant improvement in operating loss (EBIT) to CHF 7.9 million, outperforming forecasts and a substantial reduction from the CHF 23 million loss in H1 2024, attributed to a lower cost base. While net income remained a loss of CHF 12.9 million and operating free cash flow negative, the company anticipates a challenging market environment but projects improved full-year 2025 EBIT and targets a medium-term adjusted EBIT margin of 5-7% at CHF 800 million sales.

Analysis

Bystronic's first-half 2025 results present a mixed but cautiously optimistic picture, primarily driven by successful cost management rather than market recovery. Order intake of CHF 309 million and revenue of CHF 305 million were largely in line with consensus, showing marginal year-over-year growth but a slight sequential decline from the second half of 2024, indicating a still-fragile demand environment. The key highlight is the significant improvement in profitability; the operating loss (EBIT) narrowed to CHF 7.9 million from a CHF 23 million loss a year prior, beating expectations and reflecting a lower cost base. However, the company remains in a loss-making position with a net loss of CHF 12.9 million and continues to burn cash, evidenced by a negative operating free cash flow of CHF 23 million and a reduction in net cash to CHF 306 million. Regional performance underscores the challenging market, with positive development in Southern Europe offset by sluggishness in the US agricultural segment and restraint in Central Europe. The company's cautious outlook for the remainder of 2025, projecting slightly lower sales but improved EBIT, hinges on market stabilization, while the medium-term target of a 5-7% EBIT margin sets a clear benchmark for its recovery trajectory.

Key Decisions for Investors

• Investors should recognize the significant improvement in operating loss as a positive signal that cost controls are effective, providing operational leverage for a potential market recovery.
• Closely monitor sequential order intake and operating free cash flow, as continued weakness in these metrics presents the primary risk to the turnaround thesis and could pressure the balance sheet.
• Consider the stock as a potential turnaround play, using the medium-term guidance of a 5-7% EBIT margin on CHF 800 million in sales as a key valuation benchmark, while acknowledging that achieving this is dependent on a market recovery that management views as uncertain.